Study of phosphodiesterase inhibitors on lipolysis, phosphodiesterase activity and cyclic 3',5'-adenosine monophosphate levels in isolated fat cells.
D000273:Adipose Tissue / Q000201:enzymology / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000008:administration & dosage / Q000378:metabolism*; D004837:Epinephrine / Q000494:pharmacology; D006834:Hydrazines / Q000494:pharmacology; D050356:Lipid Metabolism; D008297:Male; D010208:Papaverine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D006005:Phosphorylases / Q000378:metabolism; D011720:Pyrazoles / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D013806:Theophylline / Q000008:administration & dosage / Q000494:pharmacology
D006834:Hydrazines; D010726:Phosphodiesterase Inhibitors; D011720:Pyrazoles; D011725:Pyridines; D000324:Adrenocorticotropic Hormone; D013806:Theophylline; D010208:Papaverine; D000242:Cyclic AMP; D006005:Phosphorylases; D010727:Phosphoric Diester Hydrolases; D004837:Epinephrine